Flagship Harbor Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $721K | Buy |
1,620
+85
| +6% | +$37.8K | 0.03% | 383 |
|
2025
Q1 | $744K | Buy |
1,535
+13
| +0.9% | +$6.3K | 0.04% | 343 |
|
2024
Q4 | $613K | Hold |
1,522
| – | – | 0.03% | 371 |
|
2024
Q3 | $708K | Buy |
+1,522
| New | +$708K | 0.04% | 339 |
|
2024
Q1 | $798K | Sell |
1,908
-4
| -0.2% | -$1.67K | 0.05% | 280 |
|
2023
Q4 | $778K | Buy |
1,912
+341
| +22% | +$139K | 0.06% | 262 |
|
2023
Q3 | $546K | Buy |
1,571
+70
| +5% | +$24.3K | 0.05% | 307 |
|
2023
Q2 | $528K | Buy |
1,501
+100
| +7% | +$35.2K | 0.04% | 317 |
|
2023
Q1 | $441K | Sell |
1,401
-261
| -16% | -$82.2K | 0.04% | 378 |
|
2022
Q4 | $480K | Sell |
1,662
-62
| -4% | -$17.9K | 0.05% | 346 |
|
2022
Q3 | $499K | Buy |
1,724
+406
| +31% | +$118K | 0.06% | 312 |
|
2022
Q2 | $371K | Buy |
1,318
+14
| +1% | +$3.94K | 0.04% | 388 |
|
2022
Q1 | $340K | Sell |
1,304
-12
| -0.9% | -$3.13K | 0.03% | 446 |
|
2021
Q4 | $289K | Buy |
1,316
+214
| +19% | +$47K | 0.03% | 506 |
|
2021
Q3 | $222K | Hold |
1,102
| – | – | 0.02% | 576 |
|
2021
Q2 | $222K | Buy |
+1,102
| New | +$222K | 0.02% | 577 |
|
2020
Q4 | – | Sell |
-794
| Closed | -$216K | – | 1717 |
|
2020
Q3 | $216K | Buy |
794
+74
| +10% | +$20.1K | 0.03% | 449 |
|
2020
Q2 | $209K | Buy |
720
+148
| +26% | +$43K | 0.03% | 451 |
|
2020
Q1 | $136K | Buy |
572
+58
| +11% | +$13.8K | 0.03% | 473 |
|
2019
Q4 | $113K | Hold |
514
| – | – | 0.02% | 580 |
|
2019
Q3 | $87K | Hold |
514
| – | – | 0.02% | 623 |
|
2019
Q2 | $94K | Buy |
514
+16
| +3% | +$2.93K | 0.02% | 587 |
|
2019
Q1 | $91K | Hold |
498
| – | – | 0.02% | 586 |
|
2018
Q4 | $82K | Sell |
498
-228
| -31% | -$37.5K | 0.02% | 569 |
|
2018
Q3 | $139K | Sell |
726
-11
| -1% | -$2.11K | 0.03% | 505 |
|
2018
Q2 | $125K | Buy |
+737
| New | +$125K | 0.03% | 516 |
|